Readgene
Readgene operates in Biotechnology.
Market Cap & Net Worth: Readgene (RDG)
Readgene (WAR:RDG) has a market capitalization of $12.97K (zł53.92K) as of March 18, 2026. Listed on the WAR stock exchange, this Poland-based company holds position #44563 globally and #446 in its home market, demonstrating a 25.81% increase in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying Readgene's stock price zł5.46 by its total outstanding shares 9876 (9.88K).
Readgene Market Cap History: 2015 to 2026
Readgene's market capitalization history from 2015 to 2026. Data shows growth from $2.90K to $12.97K (12.98% CAGR).
Readgene Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how Readgene's valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance.
Latest Price to Sales (P/S) Ratio
0.00x
Readgene's market cap is 0.00 times its annual revenue
0.16x
Lower than industry averageLatest Price to Earnings (P/E) Ratio
N/A
P/E ratio not applicable due to negative or zero earnings
What These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| 2015 | $2.90K | $2.19 Million | -$676.90K | 0.00x | N/A |
| 2016 | $3.06K | $5.23 Million | -$493.89K | 0.00x | N/A |
| 2017 | $3.71K | $2.62 Million | -$43.31K | 0.00x | N/A |
| 2018 | $1.07K | $4.83 Million | $911.11K | 0.00x | 0.00x |
| 2019 | $1.57K | $4.10 Million | -$76.53K | 0.00x | N/A |
| 2020 | $6.18K | $4.05 Million | $226.35K | 0.00x | 0.03x |
| 2021 | $6.67K | $6.45 Million | $37.88K | 0.00x | 0.18x |
| 2022 | $6.13K | $7.24 Million | $213.23K | 0.00x | 0.03x |
| 2023 | $13.78K | $10.15 Million | -$1.35 Million | 0.00x | N/A |
Competitor Companies of RDG by Market Capitalization
Companies near Readgene in the global market cap rankings as of March 18, 2026.
Key companies related to Readgene by market ranking:
- Peptron Inc (KQ:087010): Ranked #3322 globally with a market cap of $3.92 Billion USD ( ₩5.74 Trillion KRW).
- MEDIPOST Co. Ltd (KQ:078160): Ranked #15247 globally with a market cap of $192.41 Million USD ( ₩281.72 Billion KRW).
- Bioneer Corporation (KQ:064550): Ranked #15689 globally with a market cap of $175.97 Million USD ( ₩257.66 Billion KRW).
- Macrogen Inc (KQ:038290): Ranked #18272 globally with a market cap of $99.40 Million USD ( ₩145.55 Billion KRW).
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #3322 | Peptron Inc | KQ:087010 | $3.92 Billion | ₩311000.00 |
| #15247 | MEDIPOST Co. Ltd | KQ:078160 | $192.41 Million | ₩22200.00 |
| #15689 | Bioneer Corporation | KQ:064550 | $175.97 Million | ₩12100.00 |
| #18272 | Macrogen Inc | KQ:038290 | $99.40 Million | ₩16410.00 |
Readgene Historical Marketcap From 2015 to 2026
Between 2015 and today, Readgene's market cap moved from $2.90K to $ 12.97K, with a yearly change of 12.98%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2026 | zł12.97K | 0.00% |
| 2025 | zł12.97K | +10.08% |
| 2024 | zł11.78K | -14.48% |
| 2023 | zł13.78K | +124.81% |
| 2022 | zł6.13K | -8.19% |
| 2021 | zł6.67K | +8.08% |
| 2020 | zł6.18K | +293.94% |
| 2019 | zł1.57K | +46.67% |
| 2018 | zł1.07K | -71.15% |
| 2017 | zł3.71K | +20.93% |
| 2016 | zł3.06K | +5.74% |
| 2015 | zł2.90K | -- |
End of Day Market Cap According to Different Sources
On Mar 18th, 2026 the market cap of Readgene was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $12.97K USD |
| MoneyControl | $12.97K USD |
| MarketWatch | $12.97K USD |
| marketcap.company | $12.97K USD |
| Reuters | $12.97K USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.